Table of Content

1. Executive Summary
   1. Global Retinopathy of Prematurity Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. COVID-19 Impact Analysis
   4. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Value Chain Analysis
   2. Key Market Players
   3. Regulatory Landscape
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
   6. Consumer Behavior Analysis
4. Price Trend Analysis, 2019 - 2032
   1. Key Factors Impacting Product Prices
   2. Pricing Analysis, By Type of Treatment
   3. Regional Prices and Product Preferences
5. Global Retinopathy of Prematurity Market Outlook
   1. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
   2. Global Retinopathy of Prematurity Market Outlook: Type of Treatment
      1. Historical Market Size (US$ Bn) Analysis, By Type of Treatment, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Type of Treatment, 2025-2032
         1. Laser Therapy
         2. Cryotherapy
         3. Pharmaceuticals
         4. Surgery
      3. Market Attractiveness Analysis: Type of Treatment
   3. Global Retinopathy of Prematurity Market Outlook: Age Group
      1. Historical Market Size (US$ Bn) Analysis, By Age Group, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025-2032
         1. Premature Infants
         2. Low Birth Weight Infants
         3. Very Low Birth Weight Infants
      3. Market Attractiveness Analysis: Age Group
   4. Global Retinopathy of Prematurity Market Outlook: Diagnosis Method
      1. Historical Market Size (US$ Bn) Analysis, By Diagnosis Method, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Diagnosis Method, 2025-2032
         1. Retinal Examination
         2. Imaging Techniques
         3. Visual Function Assessment
      3. Market Attractiveness Analysis: Diagnosis Method
   5. Global Retinopathy of Prematurity Market Outlook: End-use
      1. Historical Market Size (US$ Bn) Analysis, By End-use, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
         1. Hospitals
         2. Clinics
         3. Research Institutes
      3. Market Attractiveness Analysis: End-use
6. Global Retinopathy of Prematurity Market Outlook: Region
   1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
   2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
   3. Market Attractiveness Analysis: Region
7. North America Retinopathy of Prematurity Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Type of Treatment
      3. By Age Group
      4. By Diagnosis Method
      5. By End-use
   2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
   3. Market Size (US$ Bn) Analysis and Forecast, By Type of Treatment, 2025-2032
      1. Laser Therapy
      2. Cryotherapy
      3. Pharmaceuticals
      4. Surgery
   4. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025-2032
      1. Premature Infants
      2. Low Birth Weight Infants
      3. Very Low Birth Weight Infants
   5. Market Size (US$ Bn) Analysis and Forecast, By Diagnosis Method, 2025-2032
      1. Retinal Examination
      2. Imaging Techniques
      3. Visual Function Assessment
   6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      1. Hospitals
      2. Clinics
      3. Research Institutes
   7. Market Attractiveness Analysis
8. Europe Retinopathy of Prematurity Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Type of Treatment
      3. By Age Group
      4. By Diagnosis Method
      5. By End-use
   2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   3. Market Size (US$ Bn) Analysis and Forecast, By Type of Treatment, 2025-2032
      1. Laser Therapy
      2. Cryotherapy
      3. Pharmaceuticals
      4. Surgery
   4. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025-2032
      1. Premature Infants
      2. Low Birth Weight Infants
      3. Very Low Birth Weight Infants
   5. Market Size (US$ Bn) Analysis and Forecast, By Diagnosis Method, 2025-2032
      1. Retinal Examination
      2. Imaging Techniques
      3. Visual Function Assessment
   6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      1. Hospitals
      2. Clinics
      3. Research Institutes
   7. Market Attractiveness Analysis
9. East Asia Retinopathy of Prematurity Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Type of Treatment
      3. By Age Group
      4. By Diagnosis Method
      5. By End-use
   2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
   3. Market Size (US$ Bn) Analysis and Forecast, By Type of Treatment, 2025-2032
      1. Laser Therapy
      2. Cryotherapy
      3. Pharmaceuticals
      4. Surgery
   4. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025-2032
      1. Premature Infants
      2. Low Birth Weight Infants
      3. Very Low Birth Weight Infants
   5. Market Size (US$ Bn) Analysis and Forecast, By Diagnosis Method, 2025-2032
      1. Retinal Examination
      2. Imaging Techniques
      3. Visual Function Assessment
   6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      1. Hospitals
      2. Clinics
      3. Research Institutes
   7. Market Attractiveness Analysis
10. South Asia & Oceania Retinopathy of Prematurity Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Type of Treatment
       3. By Age Group
       4. By Diagnosis Method
       5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
       1. India
       2. Indonesia
       3. Thailand
       4. Singapore
       5. ANZ
       6. Rest of South Asia & Oceania
    3. Market Size (US$ Bn) Analysis and Forecast, By Type of Treatment, 2025-2032
       1. Laser Therapy
       2. Cryotherapy
       3. Pharmaceuticals
       4. Surgery
    4. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025-2032
       1. Premature Infants
       2. Low Birth Weight Infants
       3. Very Low Birth Weight Infants
    5. Market Size (US$ Bn) Analysis and Forecast, By Diagnosis Method, 2025-2032
       1. Retinal Examination
       2. Imaging Techniques
       3. Visual Function Assessment
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
       1. Hospitals
       2. Clinics
       3. Research Institutes
    7. Market Attractiveness Analysis
11. Latin America Retinopathy of Prematurity Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Type of Treatment
       3. By Age Group
       4. By Diagnosis Method
       5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    3. Market Size (US$ Bn) Analysis and Forecast, By Type of Treatment, 2025-2032
       1. Laser Therapy
       2. Cryotherapy
       3. Pharmaceuticals
       4. Surgery
    4. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025-2032
       1. Premature Infants
       2. Low Birth Weight Infants
       3. Very Low Birth Weight Infants
    5. Market Size (US$ Bn) Analysis and Forecast, By Diagnosis Method, 2025-2032
       1. Retinal Examination
       2. Imaging Techniques
       3. Visual Function Assessment
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
       1. Hospitals
       2. Clinics
       3. Research Institutes
    7. Market Attractiveness Analysis
12. Middle East & Africa Retinopathy of Prematurity Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Type of Treatment
       3. By Age Group
       4. By Diagnosis Method
       5. By End-use
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    3. Market Size (US$ Bn) Analysis and Forecast, By Type of Treatment, 2025-2032
       1. Laser Therapy
       2. Cryotherapy
       3. Pharmaceuticals
       4. Surgery
    4. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025-2032
       1. Premature Infants
       2. Low Birth Weight Infants
       3. Very Low Birth Weight Infants
    5. Market Size (US$ Bn) Analysis and Forecast, By Diagnosis Method, 2025-2032
       1. Retinal Examination
       2. Imaging Techniques
       3. Visual Function Assessment
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
       1. Hospitals
       2. Clinics
       3. Research Institutes
    7. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Pfizer
          1. Overview
          2. Segments and Type of Treatment
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Mylan
       3. Apellis Pharmaceuticals
       4. EyePoint Pharmaceuticals
       5. Hikma Pharmaceuticals
       6. Aerie Pharmaceuticals
       7. Roche
       8. Horizon Therapeutics
       9. Santen Pharmaceutical
       10. Bayer
       11. Novartis
       12. Allergan
       13. Regeneron Pharmaceuticals
       14. Alergan
       15. Eagle Pharmaceuticals
       16. Others
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations